APA (7th ed.) Citation

Zhang, M., Li, M., Ou, Y., Huang, Q., Leng, M., Yang, X., & Yang, T. (2025). Infliximab for patients with moderate to severely active ulcerative colitis: An updated meta-analysis of randomized controlled trials. BMC Gastroenterology, 25(1), 1. https://doi.org/10.1186/s12876-025-04065-w

Chicago Style (17th ed.) Citation

Zhang, Min, Manman Li, Yangzan Ou, Qin Huang, Mingmin Leng, Xiangdong Yang, and Tao Yang. "Infliximab for Patients with Moderate to Severely Active Ulcerative Colitis: An Updated Meta-analysis of Randomized Controlled Trials." BMC Gastroenterology 25, no. 1 (2025): 1. https://doi.org/10.1186/s12876-025-04065-w.

MLA (9th ed.) Citation

Zhang, Min, et al. "Infliximab for Patients with Moderate to Severely Active Ulcerative Colitis: An Updated Meta-analysis of Randomized Controlled Trials." BMC Gastroenterology, vol. 25, no. 1, 2025, p. 1, https://doi.org/10.1186/s12876-025-04065-w.